Literature DB >> 17471564

A prospective study of dietary flavonoid intake and incidence of epithelial ovarian cancer.

Margaret A Gates1, Shelley S Tworoger, Jonathan L Hecht, Immaculata De Vivo, Bernard Rosner, Susan E Hankinson.   

Abstract

Flavonoids are antioxidant compounds found in plants, including fruits, vegetables and tea. No prior prospective studies have examined the association between intake of flavonoids in the flavonol and flavone subclasses and ovarian cancer risk. We analyzed the association between intake of 5 common dietary flavonoids and incidence of epithelial ovarian cancer among 66,940 women in the Nurses' Health Study. We calculated each participant's intake of myricetin, kaempferol, quercetin, luteolin and apigenin from dietary data collected at multiple time points, and used Cox proportional hazards regression to model the incidence rate ratio (RR) of ovarian cancer for each quintile of intake. Our analysis included 347 cases diagnosed between 1984 and 2002, and 950,347 person-years of follow-up. There was no clear association between total intake of the 5 flavonoids examined and incidence of ovarian cancer (RR = 0.75 for the highest versus lowest quintile, 95% confidence interval [CI] = 0.51-1.09). However, there was a significant 40% decrease in ovarian cancer incidence for the highest versus lowest quintile of kaempferol intake (RR = 0.60, 95% CI = 0.42-0.87; p-trend = 0.002), and a significant 34% decrease in incidence for the highest versus lowest quintile of luteolin intake (RR = 0.66, 95% CI = 0.49-0.91; p-trend = 0.01). There was evidence of an inverse association with consumption of tea (nonherbal) and broccoli, the primary contributors to kaempferol intake in our population. These data suggest that dietary intake of certain flavonoids may reduce ovarian cancer risk, although additional prospective studies are needed to further evaluate this association. If confirmed, these results would provide an important target for ovarian cancer prevention. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17471564     DOI: 10.1002/ijc.22790

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  85 in total

1.  Apigenin attenuates insulin-like growth factor-I signaling in an autochthonous mouse prostate cancer model.

Authors:  Sanjeev Shukla; Gregory T MacLennan; Pingfu Fu; Sanjay Gupta
Journal:  Pharm Res       Date:  2011-12-03       Impact factor: 4.200

2.  In Vivo Exposure of Kaempferol Is Driven by Phase II Metabolic Enzymes and Efflux Transporters.

Authors:  Liang Zheng; Lijun Zhu; Min Zhao; Jian Shi; Yuhuan Li; Jia Yu; Huangyu Jiang; Jinjun Wu; Yunli Tong; Yuting Liu; Ming Hu; Linlin Lu; Zhongqiu Liu
Journal:  AAPS J       Date:  2016-07-08       Impact factor: 4.009

3.  Single nucleotide polymorphisms in the TP53 region and susceptibility to invasive epithelial ovarian cancer.

Authors:  Joellen M Schildkraut; Ellen L Goode; Merlise A Clyde; Edwin S Iversen; Patricia G Moorman; Andrew Berchuck; Jeffrey R Marks; Jolanta Lissowska; Louise Brinton; Beata Peplonska; Julie M Cunningham; Robert A Vierkant; David N Rider; Georgia Chenevix-Trench; Penelope M Webb; Jonathan Beesley; Xiaoqing Chen; Catherine Phelan; Rebecca Sutphen; Thomas A Sellers; Leigh Pearce; Anna H Wu; David Van Den Berg; David Conti; Christopher K Elund; Rebecca Anderson; Marc T Goodman; Galina Lurie; Michael E Carney; Pamela J Thompson; Simon A Gayther; Susan J Ramus; Ian Jacobs; Susanne Krüger Kjaer; Estrid Hogdall; Jan Blaakaer; Claus Hogdall; Douglas F Easton; Honglin Song; Paul D P Pharoah; Alice S Whittemore; Valerie McGuire; Lydia Quaye; Hoda Anton-Culver; Argyrios Ziogas; Kathryn L Terry; Daniel W Cramer; Susan E Hankinson; Shelley S Tworoger; Brian Calingaert; Stephen Chanock; Mark Sherman; Montserrat Garcia-Closas
Journal:  Cancer Res       Date:  2009-03-10       Impact factor: 12.701

Review 4.  Dietary intake and ovarian cancer risk: a systematic review.

Authors:  Tracy E Crane; Beman R Khulpateea; David S Alberts; Karen Basen-Engquist; Cynthia A Thomson
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-10-18       Impact factor: 4.254

5.  Effect of luteolin on the methylation status of the OPCML gene and cell growth in breast cancer cells.

Authors:  Xinmin Dong; Jian Zhang; Fan Yang; Jing Wu; Rui Cai; Tian Wang; Jiren Zhang
Journal:  Exp Ther Med       Date:  2018-07-26       Impact factor: 2.447

6.  Plant flavone apigenin: An emerging anticancer agent.

Authors:  Eswar Shankar; Aditi Goel; Karishma Gupta; Sanjay Gupta
Journal:  Curr Pharmacol Rep       Date:  2017-10-14

7.  Dietary flavonoids modulate CYP2C to improve drug oral bioavailability and their qualitative/quantitative structure-activity relationship.

Authors:  Hong-Jaan Wang; Li-Heng Pao; Cheng-Huei Hsiong; Tung-Yuan Shih; Meei-Shyuan Lee; Oliver Yoa-Pu Hu
Journal:  AAPS J       Date:  2014-01-16       Impact factor: 4.009

Review 8.  Luteolin, a flavonoid with potential for cancer prevention and therapy.

Authors:  Yong Lin; Ranxin Shi; Xia Wang; Han-Ming Shen
Journal:  Curr Cancer Drug Targets       Date:  2008-11       Impact factor: 3.428

Review 9.  A review of the dietary flavonoid, kaempferol on human health and cancer chemoprevention.

Authors:  Allen Y Chen; Yi Charlie Chen
Journal:  Food Chem       Date:  2012-12-28       Impact factor: 7.514

10.  Kaempferol inhibits angiogenesis and VEGF expression through both HIF dependent and independent pathways in human ovarian cancer cells.

Authors:  Haitao Luo; Gary O Rankin; Lingzhi Liu; Matthew K Daddysman; Bing-Hua Jiang; Yi Charlie Chen
Journal:  Nutr Cancer       Date:  2009       Impact factor: 2.900

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.